MedZilla

Egalet is a fully integrated specialty pharmaceutical company focused on developing and commercializing treatments for those living with pain. Egalet was founded around its proprietary Guardian Technology that can be applied broadly across different classes of pharmaceutical products. Using this technology, Egalet developed ARYMO ER (morphine sulfate) extended-release tablets C-II, an extended-release morphine product formulated with abuse-deterrent properties, which is marketed and approved for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. In addition, Egalet also markets two other innovative pain products SPRIX (ketorolac tromethamine) Nasal Spray, and OXAYDO (oxycodone HCl, USP) Tablets for oral use only CII.